Earnings
📈 Stocks
Reviva Pharmaceuticals Reports Q3 Net Loss of $2.3 Million
(just now)
Reviva Pharmaceuticals narrowed its Q3 net loss to $2.3 million while awaiting FDA feedback on a new brilaroxazine formulation, with Phase 3…